Xiangyu Medical Co (SHSE:688626) Debt-to-Equity : 0.14 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Xiangyu Medical Co Debt-to-Equity?

Xiangyu Medical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥287.0 Mil. Xiangyu Medical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥8.5 Mil. Xiangyu Medical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,078.0 Mil. Xiangyu Medical Co's debt to equity for the quarter that ended in Mar. 2024 was 0.14.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Xiangyu Medical Co's Debt-to-Equity or its related term are showing as below:

SHSE:688626' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.07 Max: 0.14
Current: 0.14

During the past 7 years, the highest Debt-to-Equity Ratio of Xiangyu Medical Co was 0.14. The lowest was 0.00. And the median was 0.07.

SHSE:688626's Debt-to-Equity is ranked better than
61.22% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs SHSE:688626: 0.14

Xiangyu Medical Co Debt-to-Equity Historical Data

The historical data trend for Xiangyu Medical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangyu Medical Co Debt-to-Equity Chart

Xiangyu Medical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.07

0.01

0.02

Xiangyu Medical Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.04	0.08	0.12	0.02	0.14

Competitive Comparison of Xiangyu Medical Co's Debt-to-Equity

For the Medical Devices subindustry, Xiangyu Medical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xiangyu Medical Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xiangyu Medical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Xiangyu Medical Co's Debt-to-Equity falls into.

Xiangyu Medical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Xiangyu Medical Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(27.015	+	8.443)	/	2090.901
	=	0.02

Xiangyu Medical Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(287.015	+	8.543)	/	2077.979
	=	0.14

Xiangyu Medical Co (SHSE:688626) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Xiangyu Medical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Xiangyu Medical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangyu Medical Co (SHSE:688626) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xiangyu Medical Co Ltd (SHSE:688626) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Middle Section of Dixu Avenue, Neihuang County, Henan Province, Anyang, CHN, 456300

Website

http://www.xyyl.com

Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.

Executives

He Yong Zheng

Director, core technical staff

Xiangyu Medical Co (SHSE:688626) Headlines

No Headlines